These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33057730)

  • 1. A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.
    Francisco GE; Balbert A; Bavikatte G; Bensmail D; Carda S; Deltombe T; Draulans N; Escaldi S; Gross R; Jacinto J; Ketchum N; Molteni F; Moraleda S; ODell MW; Reebye R; Säterö P; Verduzco-Gutierrez M; Walker H; Wissel J
    J Rehabil Med; 2021 Jan; 53(1):jrm00134. PubMed ID: 33057730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early pharmacologic treatment with botulinum toxin A in post-stroke spasticity: consensus evidence-based recommendations].
    Lopez de Munain L; Juan-Garcia FJ; Duarte E; Martin-Mourelle R; Rodriguez S; Moraleda-Perez S
    Rev Neurol; 2016 Oct; 63(8):363-369. PubMed ID: 27699753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial.
    Kerzoncuf M; Viton JM; Pellas F; Cotinat M; Calmels P; Milhe de Bovis V; Delarque A; Bensoussan L
    Arch Phys Med Rehabil; 2020 Feb; 101(2):242-248. PubMed ID: 31469982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature.
    Picelli A; Santamato A; Chemello E; Cinone N; Cisari C; Gandolfi M; Ranieri M; Smania N; Baricich A
    Ann Phys Rehabil Med; 2019 Jul; 62(4):291-296. PubMed ID: 30219307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
    Chu WH; Gupta AD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors.
    Franceschini M; Iocco M; Molteni F; Santamato A; Smania N;
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):525-33. PubMed ID: 24963604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke, spasticity, and botulinum toxin.
    Rowland LP
    N Engl J Med; 2002 Aug; 347(6):382-3. PubMed ID: 12167679
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity.
    Bakheit AM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):665-6. PubMed ID: 15090554
    [No Abstract]   [Full Text] [Related]  

  • 13. [The features of botulinum therapy for different patterns of poststroke spasticity].
    Krylova LV; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):42-48. PubMed ID: 28374692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
    Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey.
    Sandrini G; Baricich A; Cisari C; Paolucci S; Smania N; Picelli A
    Funct Neurol; 2018; 33(1):37-43. PubMed ID: 29633695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European consensus table on the use of botulinum toxin type A in adult spasticity.
    Wissel J; Ward AB; Erztgaard P; Bensmail D; Hecht MJ; Lejeune TM; Schnider P; Altavista MC; Cavazza S; Deltombe T; Duarte E; Geurts AC; Gracies JM; Haboubi NH; Juan FJ; Kasch H; Kätterer C; Kirazli Y; Manganotti P; Parman Y; Paternostro-Sluga T; Petropoulou K; Prempeh R; Rousseaux M; Slawek J; Tieranta N
    J Rehabil Med; 2009 Jan; 41(1):13-25. PubMed ID: 19197564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment.
    Kinnear BZ
    Syst Rev; 2012 Jun; 1():29. PubMed ID: 22734503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.